Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

397 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of resistance training on sleep quality and disorders among individuals diagnosed with cancer: A systematic review and meta-analysis of randomized controlled trials.
Maric D, Ficarra S, Di Bartolo L, Rossi C, Asimakopoulou Z, Vantarakis A, Carbonell-Baeza A, Jiménez-Pavón D, Gomes B, Tavares P, Baxter R, Pusa S, Thaller P, Papakonstantinou S, Kirkar M, Glorioso F, Galioto M, Gentile A, Thomas E, Bianco A. Maric D, et al. Among authors: tavares p. Cancer Med. 2024 Apr;13(8):e7179. doi: 10.1002/cam4.7179. Cancer Med. 2024. PMID: 38650577 Free PMC article. Review.
Melanoma prevention using an augmented reality-based serious game.
Ribeiro N, Tavares P, Ferreira C, Coelho A. Ribeiro N, et al. Among authors: tavares p. Patient Educ Couns. 2024 Jun;123:108226. doi: 10.1016/j.pec.2024.108226. Epub 2024 Feb 24. Patient Educ Couns. 2024. PMID: 38442436 Free article.
One more rep! The case for resistance training in young cancer survivors.
Lakicevic N, Ficarra S, Ortega-Gómez S, Jiménez-Pavón D, Asimakopoulou Z, Vantarakis A, Tavares P, Vaz V, Thaller J, Papakonstantinou S, Kirkar M, Glorioso F, Palma A, Bianco A. Lakicevic N, et al. Among authors: tavares p. Front Oncol. 2023 Dec 4;13:1284052. doi: 10.3389/fonc.2023.1284052. eCollection 2023. Front Oncol. 2023. PMID: 38111526 Free PMC article.
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Tuttle KR, Hauske SJ, Canziani ME, Caramori ML, Cherney D, Cronin L, Heerspink HJL, Hugo C, Nangaku M, Rotter RC, Silva A, Shah SV, Sun Z, Urbach D, de Zeeuw D, Rossing P; ASi in CKD group. Tuttle KR, et al. Lancet. 2024 Jan 27;403(10424):379-390. doi: 10.1016/S0140-6736(23)02408-X. Epub 2023 Dec 15. Lancet. 2024. PMID: 38109916 Clinical Trial.
Choose the healthy way! Physical activity as a tool to improve mental health in young cancer survivors.
Gentile A, Ficarra S, Ortega-Gómez S, Jiménez-Pavón D, Asimakopoulou Z, Vantarakis A, Tavares P, Vaz V, Thaller J, Papakonstantinou S, Kirkar M, Glorioso F, Galioto M, Lo Mauro M, Bianco A. Gentile A, et al. Among authors: tavares p. Acta Oncol. 2023 Dec;62(12):1589-1591. doi: 10.1080/0284186X.2023.2270154. Epub 2023 Nov 25. Acta Oncol. 2023. PMID: 37837211 No abstract available.
Subversion strategies of lysosomal killing by intracellular pathogens.
Teixeira SC, Teixeira TL, Tavares PCB, Alves RN, da Silva AA, Borges BC, Martins FA, Dos Santos MA, de Castilhos P, E Silva Brígido RT, Notário AFO, Silveira ACA, da Silva CV. Teixeira SC, et al. Among authors: tavares pcb. Microbiol Res. 2023 Dec;277:127503. doi: 10.1016/j.micres.2023.127503. Epub 2023 Sep 22. Microbiol Res. 2023. PMID: 37748260 Review.
397 results